Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors

Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors

Abstract Aims Sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) have been shown to have a relevant role in the prevention of hospitalizations for heart failure and improvement in the life expectancy of patients with diabetes and outpatients with chronic heart failure (CHF) with reduced left ventri...

Full description

Bibliographic Details
Main Authors: Gianmarco Angelini, Miriam Albanese, Raffaella Ursi, Francesco Lisi, Maria Consiglia Bellino, Luca Amato, Margherita Ilaria Gioia, Giuseppe Parisi, Natale Daniele Brunetti, Giuseppina Piazzolla, Marco Matteo Ciccone, Massimo Iacoviello
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Type 2 diabetes mellitus
Sodium–glucose co‐transporter inhibitor
Therapy
Heart failure
Online Access:https://doi.org/10.1002/ehf2.13380

Internet

https://doi.org/10.1002/ehf2.13380

Similar Items